Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

Interim Management Statement

12 Nov 2012 07:00

RNS Number : 8162Q
Raven Russia Limited
12 November 2012
 



12 November 2012

 

Raven Russia Limited ("Raven Russia" or the "Company")

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 JULY 2012 TO 12 NOVEMBER 2012

 

 

Key Highlights

 

·; Annualised, consolidated NOI now $168 million, increasing to $170 million including Letters of Intent ("LOIs")

 

·; Portfolio 95% let

 

·; Construction commenced on new build of 19,000 sqm at Noginsk and 30,000 sqm at Klimovsk phase 3 projects, for delivery Q2 2013

 

·; Preparatory work commenced on the Padikovo project

 

·; Construction financed by a $30m facility with DEG bank, drawn at end of October

 

·; Refinancing of Klimovsk phase 2 project to complete this quarter

 

·; Terms agreed to refinance Krekshino and Constanta projects

 

·; Tender offer buy back at 75p fully subscribed and completed on 26 October 2012

 

·; Group cash balance currently $156 million

 

 

Overview

 

The letting market in our sector remains strong as we head towards the year end. We expect our assets in Moscow, St Petersburg and Rostov to be virtually fully let by 31 December. Novosibirsk is the slowest of the markets we operate in but continues to show steady interest.

 

At today's date, we have annualised net operating income ("NOI") of $168 million, increasing to $170 million including LOIs and to $177 million when fully let.

 

We have now turned to a managed development programme of our Moscow land bank and have commenced construction of 49,000 square metres ("sqm") of new space: 19,000 sqm at our Noginsk project; and 30,000 sqm at our Klimovsk project. As these are new phases of existing sites, the total marginal cost of construction is budgeted at $35 million, with delivery expected at the end of Q2 2013.

 

The completion of these phases is expected to add $6.1 million of potential NOI to the portfolio.

 

Preparatory work, which will enable a further 36,000 sqm of construction at the sites, is being completed in parallel.

 

We have also commenced detailed planning work for our site at Padikovo, on the Nova Riga highway, North West Moscow, which was purchased in July this year. This will allow us to commence construction on that site in the second half of 2013, if the market remains strong.

 

 

Financial

 

Our focus in the second half of this year has been on refinancing near term bank maturities. Terms have been agreed on the refinancing of the facility secured on our Krekshino asset, which matures in January 2013. The new facility is for $100 million, with a 7 year term. We expect this facility to be finalised this quarter.

 

We have agreed terms to roll over the existing facility secured on our Constanta asset for a further 2 years.

 

There are two new facilities completing in the second half of this year. We have drawn an unsecured construction loan of $30 million from DEG bank on an 8 year term, to fund the construction programme described earlier. As an unsecured construction loan, this has a higher cost of debt of 9% than our secured facilities.

 

The second phase of our Klimovsk project is being used as security on another new facility of $47.5 million with a 10 year term and total expected cost of debt of just over 7%. All facility documents have been signed and we are awaiting confirmation of the registration of the mortgage before drawing.

 

The tender offer buy back of 1 in 49 shares at 75p announced on 11 September 2012 was fully subscribed and 12,277,785 shares were purchased on 26 October 2012 and subsequently cancelled.

 

Following the draw down of the DEG facility and tender offer buy back, the Group's cash balance is $156 million.

 

Glyn Hirsch, Chief Executive of Raven Russia said:

 

"We now have a mature portfolio of high yielding assets. To continue our steady growth, we are using our cash resources to develop selectively our Moscow land bank."

 

 

Enquiries

 

Raven Russia Limited Tel: + 44 (0) 1481 712955

Anton Bilton

Glyn Hirsch

 

Cardew Group Tel:+44 (0) 207 930 0777

Tim Robertson

Alexandra Stoneham

 

N+1 Singer Tel: +44 (0) 203 205 7500

Corporate Finance- James Maxwell

Sales - Alan Geeves / James Waterlow

 

This announcement contains forward-looking statements that involve risk and uncertainties and speak only as at the date of this announcement. The Group's actual results could differ materially from those estimated or anticipated in the forward-looking statements as a result of many factors. Information contained in this announcement relating to the Company should not be relied upon as a guide to future performance.

 

About Raven Russia

 

Raven Russia was founded in 2005 to invest in class A warehouse complexes in Russia and lease to Russian and International tenants. Its Ordinary Shares and Warrants are listed on the Main Market of the London Stock Exchange with a market capitalisation of approximately £350 million. The company operates out of offices in Guernsey, Moscow and Cyprus and has to date completed a portfolio of circa 1.3 million square metres of Grade "A" warehouses in Moscow, St Petersburg, Rostov-on-Don and Novosibirsk. For further information visit the Company's website: www.ravenrussia.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFVRLRLAIIF
Date   Source Headline
14th Jul 20175:30 pmRNSDirector/PDMR Shareholding
14th Jul 20173:00 pmRNSTotal Voting Rights
13th Jul 20177:00 amRNSResult of AGM and Tender Offer
3rd Jul 20174:00 pmRNSResult of General Meeting
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20177:00 amRNSDirector/PDMR Shareholding
29th Jun 20177:00 amRNSIssue of Preference Shares
20th Jun 20175:29 pmRNSDirector/PDMR Shareholding
13th Jun 20175:15 pmRNSResult of Placing of Convertible Preference Shares
1st Jun 20177:00 amRNSPreference Share Dividend
31st May 201710:30 amRNSTotal Voting Rights
25th May 20177:00 amRNSScrip Dividend Circular
17th May 20177:00 amRNSMoU signed with Russian Co-Op
16th May 20175:10 pmRNSProposed Placing
11th May 20177:00 amRNSPreference Share Dividend
8th May 201712:07 pmRNSSecond Price Monitoring Extn
8th May 201712:02 pmRNSPrice Monitoring Extension
3rd May 20176:15 pmRNSTotal Voting Rights
3rd May 20175:34 pmRNSDirector/PDMR Shareholding
26th Apr 20174:30 pmRNSUpdate Regarding Acquisition
21st Apr 20173:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
31st Mar 20177:00 amRNSDirector/PDMR Shareholding
30th Mar 20177:00 amRNSIssue of Preference Shares
13th Mar 20177:00 amRNSFinal Results
9th Mar 201712:00 pmRNSPreference Share Dividend
1st Mar 20177:00 amRNSAcquisition Update
23rd Feb 20177:00 amRNSScrip Dividend Circular
9th Feb 20177:00 amRNSPreference Share Dividend
2nd Feb 20177:00 amRNSBlock listing Interim Review
25th Jan 20177:00 amRNSDirector Declaration
19th Jan 20174:30 pmRNSAcquisition and Notice of Results
3rd Jan 20177:05 amRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSTotal Voting Rights
30th Dec 20167:00 amRNSIssue of Preference Shares
21st Dec 20164:00 pmRNSDirector/PDMR Shareholding
8th Dec 20164:00 pmRNSDirector/PDMR Shareholding
1st Dec 20167:00 amRNSConvertible Preference Share Dividend
24th Nov 20167:00 amRNSScrip Dividend Circular
10th Nov 20167:00 amRNSPreference Share Dividend
7th Nov 20163:00 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSTotal Voting Rights
31st Oct 20165:30 pmRNSDirector/PDMR Shareholding
14th Oct 20165:00 pmRNSResult of General Meeting and Tender Offer
14th Oct 201612:07 pmRNSSecond Price Monitoring Extn
14th Oct 201612:02 pmRNSPrice Monitoring Extension
10th Oct 201612:07 pmRNSSecond Price Monitoring Extn
10th Oct 201612:02 pmRNSPrice Monitoring Extension
3rd Oct 20167:00 amRNSTotal Voting Rights
30th Sep 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.